Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma55
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection50
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches44
Advancement in transporter-oriented nanoplatforms for cancer therapy43
Methods for fabricating oxygen releasing biomaterials42
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma41
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis39
Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein36
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer32
Correction29
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis26
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases25
Improved Antidiabetic Potential of Quercetin-Loaded Chitosan-Lecithin Nanoparticles for Effective Glycemic Control25
Emerging role of ferroptosis in diabetic retinopathy: a review25
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes24
Correction24
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells24
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review22
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice22
Ferroptosis-targeting drugs in breast cancer20
Engineered extracellular vesicle with RAGE-antagonist peptide for delivery of anti-miRNA155 oligonucleotides to inflammatory lung cells20
Protective effects of BP-1-102 against intracranial aneurysms-induced impairments in mice20
0.026398897171021